The IWK Health Centre is a major paediatric hospital and trauma centre in Halifax, Nova Scotia that provides care to maritime youth, children and women from Nova Scotia, New Brunswick and Prince Edward Island. The IWK is the largest facility in Atlantic Canada caring for patients under 20 years of age.

Corline Biomedical AB engages in the research, development, and commercialization of heparin based solutions. Its products intend to improve kidney transplantation, cell therapies, and applications. The firm operates under the following trademarks: CHC, Renaparin, Cytoparin, and CHS. The company was founded in 1991 and is headquartered in Uppsala, Sweden.

Part of Universit��t des Saarlandes, Leibniz-Institut f��r Neue Materialien gGmbH (doing business as INM �� Leibniz-Institut f��r Neue Materialien gGmbH) is a company headquartered in Saarbruecken, Germany. The firm engages in research and development of materials. It was founded in 1987 by Herbert Gleiter. Eduard Arzt is currently the CEO of the company.

Shenzhen Desheng Medical Equipment Co., Ltd., established on 2015-10-22, Business scope includes general business items:Network Information Technology,Technology development of computer hardware and software,Technical Services,technical consulting,technology transfer;computer network engineering;medical technology,Technical consultation for medical devices;Corporate Image Planning;Exhibition planning;in the advertising business;Investment Advisory(Without trust,securities,futures,Insurance and other financial services);Medical equipment R&D and technology development,Domestic Trade,Import and export of goods and technology.(law,Administrative regulations,Except for items that are subject to approval prior to registration by decision of the State Council),The licensing program is:provide medical services;Health Advisory;Medical Health Management Consulting;human resource Management,Talent intermediary service.IIkind:6820General diagnostic equipment,6841Medical testing and basic equipment,6821Medical electronic equipment,6857Disinfection and sterilization equipment and utensils,6823Medical Ultrasonic Instruments and Related Equipment,6840Clinical Laboratory Analytical Instruments,6845Extracorporeal circulation and blood treatment equipment,6854operating room,emergency room,Consulting room equipment and appliances,6858medical cold therapy,low temperature,Refrigeration equipment and appliances,6866Research and development of medical polymer materials and products,Production,Sales;;IIIkind:6823Medical Ultrasonic Instruments and Related Equipment,6840Clinical Laboratory Analytical Instruments,6845Extracorporeal circulation and blood treatment equipment,6854operating room,emergency room,Consulting room equipment and appliances,6858medical cold therapy,low temperature,Refrigeration equipment and appliances,6866Medical polymer materials and products,6870software development,Production,Sales;Hospital logistics management service.

BGI Tech Solutions Co., Ltd. (BGI-Tech), is a world leader in cutting-edge life sciences technology and premier scientific partner to the global research community. With a firm commitment to providing the highest quality services through our worldwide service network, BGI-Tech’s mission is to facilitate ground-breaking research, foster productive collaboration and accelerate scientific advancement. BGI-Tech was founded in 2012 and is headquartered in Shenzhen, China. BGI-Tech has lab facilities in Hong Kong, Wuhan (China),and Sacramento, California (United States). It also has branch offices in Europe, the Americas, Asia- Pacific, and in Beijing, Shanghai, and Guangzhou of mainland China. Its service network covers more than 100 countries and regions. Currently, BGI-Tech collaborates with over 10,000 organizations and 30,000 partners, providing highly reliable services for thousands of research projects, including several large-scale international genome projects. With diverse service experience, unique scientific expertise, BGI-Tech is committed to developing integrated omics platforms to revolutionize life science research, to accelerate the advancement of the life science industry and to address various health, agricultural, energy, and environmental issues to improve life and society.

Wuhan Wotian Ecological Technology Co., Ltd., established on 2011-03-09, Business scope includes ecological technology services and consulting;Development of ecological agricultural resources;Ecological Agriculture Planning,Design and Construction;Ecological Landscape Planning,Design and Construction;Ecological environment engineering design and construction;Water body,Soil and mountain ecological restoration engineering;land consolidation,Farmland irrigation,Water-saving irrigation special project design;Ecosystem Integration Product Manufacturing,Sales;Sales of primary agricultural products.(Involved in licensing projects,It should be operated after obtaining the permission of the relevant department)

Ildong Pharmaceutical Co., Ltd. engages in the manufacture and sale of medicines, ingredients for medicines, health supplements and special nutritional products. Its products include vitamins, antibiotics, gastric ulcer medicine, peptic ulcerative agents, and diet pills. The company was founded on August 1, 2016 and is headquartered in Seoul, South Korea.

Hitachi Ltd. is engaged in the manufacture and sale of electrical equipment. It operates through the following segments: Information Technology (IT), Energy, Industry, Mobility, Life, Hitachi High Technologies, Hitachi Construction Machinery, Hitachi Metals, Hitachi Chemical and Others. The IT segment handles systems integration, consulting, control systems, cloud services, software, IT products such as storage and servers, and automated teller machines. The Energy segment pertains to power generation systems (nuclear power, renewable energy & thermal power) and power grid systems. The Industry segment covers industrial and distribution systems, water & environment systems, and industrial equipment. The Mobility segment includes building systems like elevators & escalators, and railway systems. The Life segment manages medical equipment; life & ecosystems such as refrigerator, washing machine, room & commercial air conditioner; automotive systems including powertrain system, chassis systems and advanced driving support systems. The Hitachi High Technologies segment covers medical & life science products, analytical equipment, semiconductor manufacturing equipment, manufacturing & inspection equipment, and advanced industrial materials. The Hitachi Construction Machinery segment handles hydraulic excavators, wheel loaders, mining machines, maintenance services, civil engineering solutions, and mine operation management systems. The Hitachi Metals segment manages special steel products, base material products, magnetic materials, power electronics, and wire materials. The Hitachi Chemical segment covers functional materials (electronic materials, wiring board materials & electronic components), advanced components and systems (mobility materials, power storage devices & life science related products). The Others segment provides optical disc drives and real estate management services. The company was founded by Namihei Odaira in 1910 and is headquartered in Tokyo, Japan.

BGI Shenzhen Co., Ltd. engages in the equity investment and asset management. Its business scope includes research and development and sales of computer hardware and software and peripheral equipment technology; import and export of goods and technology; equity investment; investment in industrial development; and aquatic product farming and sales. The company was founded on August 21, 2008 and is headquartered in Shenzhen, China.

Omron Colin Co., Ltd. plans, develops, and sells medical equipment. Its products include biological information monitor such as the Accumil series and BP-608 Evolution II, automated sphygmomanometer, pulse oximeter, and blood pressure wave inspection equipment. The company was founded 1975 and is headquartered in Tokyo, Japan.

ARKRAY, Inc. engages in the manufacture and sale of medical and surgical equipment. It develops products that focus on diabetes testing and urinalysis. It also provides the medical testing systems and functional food materials. The company was founded by Tadashi Doi on June 10, 1960 and is headquartered in Kyoto, Japan.

Boston Scientific is an innovator of medical solutions that improve the health of patients around the world. Boston Scientific's products and technologies are used to diagnose or treat a wide range of medical conditions, including heart, digestive, pulmonary, vascular, urological, women's health, and chronic pain conditions. Boston Scientific has advanced the practice of less-invasive medicine by providing a broad and deep portfolio of innovative products, technologies, and services across a wide range of medical specialties. These less-invasive medical technologies provide alternatives to major surgery and other medical procedures that are typically traumatic to the body. In less-invasive procedures, devices are usually inserted into the body through natural openings or small incisions and can be guided to most areas of the anatomy to diagnose and treat a wide range of medical problems. Boston Scientific continues to innovate in these areas and is extending its innovations into new geographies and high-growth adjacency markets. Boston Scientific is dedicated to transforming lives through innovative medical solutions that improve the health of patients around the world. Boston Scientific acts with integrity and compassion to support patients, customers, our communities, and each other.

Shanxi Runsheng Daye Biomaterials Co., Ltd., established on 2002-03-12, The business scope includes animal serum(Does not contain raw materials),purchase of fur,processing,Sales;food business:Sales of cattle and beef;Technical Consulting within Biotechnology,technology development,technology transfer;Development of cell culture media,production and sales;Development of cell culture technology,Transfer and Consulting Services(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Teikoku Tsushin Kogyo Co., Ltd. engages in the manufacture and sale of electronic parts or components. It operates through the Electronic Components and Others segments. The Electronic Components segment deals with the production of electronic parts such as integrated control blocks, resistors, and switches. The Others segment handles the manufacture and sale of machineries and equipment. The company was founded on August 1, 1944 and is headquartered in Kawasaki, Japan.

Siemens AG is a technology company, which engages in the areas of automation and digitalization in the process and manufacturing industries, infrastructure for buildings and energy systems, mobility solutions for rail transport, and medical technology and digital healthcare services. It operates through the following segments: Digital Industries, Smart Infrastructure, Mobility, Siemens Healthineers, and Siemens Financial Services. The Digital Industries segment offers a product portfolio and system solutions for automation used in discrete and process industries. The Smart Infrastructure segment includes products, systems, solutions, services and software to support a transition from fossil to renewable energy sources. The Mobility segment combines all Siemens businesses in the area of passenger and freight transportation. The Siemens Healthineers segment develops, manufactures, and sells diagnostic and therapeutic products, and services to healthcare providers. The Siemens Financial Services segment focuses on financing solutions for Siemens’ customers as well as other companies in the form of debt and equity investments. The company was founded by Johann Georg Halske and Werner von Siemens on October 12, 1847 and is headquartered in Munich, Germany.

Ajinomoto Co. is a global manufacturer of high-quality seasonings, processed foods, beverages, amino acids, pharmaceuticals and specialty chemicals. For many decades Ajinomoto Co. has contributed to food culture and human health through wide-ranging application of amino acid technologies. Today, the company is becoming increasingly involved with solutions for improved food resources, human health and global sustainability. Founded in 1909 and now operating in 26 countries, Ajinomoto Co. had net sales of JPY 1,197.3 billion (USD 15.1 billion) in fiscal 2011. The Ajinomoto Group Standards of Business Conduct (hereinafter the "Standards of Conduct") describe the conduct that every member of the Ajinomoto Group must understand and practice every day in order to implement the Ajinomoto Group Philosophy in accordance with the Ajinomoto Group Way. The Standards of Conduct also represent the commitments made to all stakeholders by Ajinomoto Group companies. Ajinomoto aim to be "a group of companies that contributes to human health globally" by continually creating unique value to benefit customers. To become a global group of food companies centered on the world's No. 1 seasoning business. To become a global group of aminoscience companies that contributes to humankind with the world's No. 1 amino acid technology. To become a group of health-promoting companies with a scientific approach to good taste and health.

Weihansi Shengwu is engaged in genetic disease screening and diagnosis, abortion product detection, single gene blockade of new mutations, and a technical service platform for gene detection of genetic diseases and the prevention and control of birth defects.